CLINICAL_TRIALS
trial_result
· 2017-06-29
Clinical Trial Update: Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension [Phase 3]
Summary
A Phase 3 trial comparing two dosing regimens of bosentan in children with pulmonary arterial hypertension has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2017-06-29